Stock-Based Compensation (Tables)

3 Months Ended

Sep. 25, 2011

Stock-Based Compensation [Abstract]

Stock Option Activity

The following table summarizes the stock option activities for the three months ended September 25, 2011 (in thousands, except per share price data):

	Stock Option Shares			Weighted Average Option Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Aggregate Intrinsic Value
Outstanding, June 26, 2011		2,992		$	21.30		—	$	22,154
Granted		10		$	20.78	$	7.51		—
Exercised		(28	)	$	14.34		—	$	202
Expired or forfeited		(392	)	$	34.71		—		—
Outstanding, September 25, 2011		2,582		$	19.34		—	$	8,050

Restricted Stock Unit Activity

The following table summarizes the RSU activity for the three months ended September 25, 2011 (in thousands, except per share price data):

	Restricted Stock Units			Weighted Average Grant Date Fair Value per Share		Aggregate Intrinsic Value
Outstanding, June 26, 2011		2,051		$	21.22	$	53,501
Granted		59		$	21.59		—
Vested		(220	)	$	18.94	$	5,820
Forfeited		(10	)	$	21.52		—
Outstanding, September 25, 2011		1,880		$	21.50	$	37,920

Additional Information Relating to Stock Options and RSU's

Additional information relating to the Company’s stock based compensation plans, including employee stock options and RSUs (including RSUs with performance-based and market-based vesting criteria) at September 25, 2011 and June 26, 2011 is as follows (in thousands):

	As of
	September 25, 2011		June 26, 2011
Outstanding options exercisable		1,707		1,905
Options and RSUs available for grant		736		510
Total reserved common stock shares for stock option plans		5,198		5,553

Stock-Based Compensation Expense

For the three months ended September 25, 2011 and September 26, 2010, stock-based compensation expense associated with the Company’s stock options and RSUs (including RSUs with performance-based vesting and market-based vesting criteria) was as follows (in thousands):

	Three Months Ended
	September 25, 2011		September 26, 2010
Selling, general and administrative expense	$	2,655	$	2,923
Research and development expense		727		650
Cost of sales		325		792
Total stock-based compensation expense	$	3,707	$	4,365

Stock Options Valuation Assumptions

The fair value of the Company stock options issued during the three months ended September 25, 2011 and September 26, 2010, was determined at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:

	September 25, 2011			September 26, 2010
Expected life	3.5 years			3.5 years
Risk free interest rate		0.4	%		0.7	%
Volatility		49.6	%		41.5	%
Dividend yield		0.0	%		0.0	%